AXIM BIOTECHNOLOGIES, INC. Share-based Payment Arrangement, Expense
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Share-based Payment Arrangement, Expense of $9.61 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2024-08-19
- AXIM BIOTECHNOLOGIES, INC. share-based payment arrangement, expense for the quarter ending 2024-06-30 was $9.61K, a 50.00% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. share-based payment arrangement, expense for the quarter ending 2024-03-31 was $9.61K, a 90.74% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. share-based payment arrangement, expense for the quarter ending 2023-12-31 was $34.09K, a 84.45% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. share-based payment arrangement, expense for the quarter ending 2023-09-30 was $38.41K, a 92.57% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. share-based payment arrangement, expense for fiscal 2023 was $197.73K, a 82.15% decline from fiscal 2022.
- AXIM BIOTECHNOLOGIES, INC. share-based payment arrangement, expense for fiscal 2022 was $1.11M, a 3.17% decline from fiscal 2021.
- AXIM BIOTECHNOLOGIES, INC. share-based payment arrangement, expense for fiscal 2021 was $1.14M, a 41.28% decline from fiscal 2020.
- AXIM BIOTECHNOLOGIES, INC. share-based payment arrangement, expense for fiscal 2020 was $1.95M, a 7.02% increase from fiscal 2019.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-06-30 | $9.61K 10-Q · filed 2024-08-19 | $21.40K 10-Q · filed 2024-08-19 | $53.31K derived: sum of 3 quarters · filed 2024-08-19 | $91.73K derived: sum of 4 quarters · filed 2024-08-19 | ||
| 2024-03-31 | $9.61K 10-Q/A · filed 2024-05-22 | $43.70K derived: sum of 2 quarters · filed 2024-05-22 | $82.11K derived: sum of 3 quarters · filed 2024-05-22 | $101.34K derived: sum of 4 quarters · filed 2024-08-19 | ||
| 2023-12-31 | $34.09K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $72.50K derived: sum of 2 quarters · filed 2024-04-16 | $91.73K derived: sum of 3 quarters · filed 2024-08-19 | $197.73K 10-K · filed 2024-04-16 | ||
| 2023-09-30 | $38.41K 10-Q · filed 2023-11-20 | $57.64K derived: sum of 2 quarters · filed 2024-08-19 | $163.64K 10-Q · filed 2023-11-20 | $380.64K derived: sum of 4 quarters · filed 2024-08-19 | ||
| 2023-06-30 | $19.23K 10-Q · filed 2024-08-19 | $21.40K 10-Q · filed 2023-08-21 | $125.23K 10-Q · filed 2024-08-19 | $342.23K derived: sum of 3 quarters · filed 2024-08-19 | $859.41K derived: sum of 4 quarters · filed 2024-08-19 | |
| 2023-03-31 | $103.82K 10-Q/A · filed 2024-05-22 | $323.00K derived: sum of 2 quarters · filed 2024-05-22 | $840.18K derived: sum of 3 quarters · filed 2024-05-22 | $1.02M derived: sum of 4 quarters · filed 2024-05-22 | ||
| 2022-12-31 | $219.18K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $736.36K derived: sum of 2 quarters · filed 2024-04-16 | $918.58K derived: sum of 3 quarters · filed 2024-04-16 | $1.11M 10-K · filed 2024-04-16 | ||
| 2022-09-30 | $517.18K 10-Q · filed 2023-11-20 | $699.39K derived: sum of 2 quarters · filed 2023-11-20 | $888.31K 10-Q · filed 2023-11-20 | $1.08M derived: sum of 4 quarters · filed 2023-11-20 | ||
| 2022-06-30 | $182.22K 10-Q · filed 2023-08-21 | $371.13K 10-Q · filed 2023-08-21 | $561.79K derived: sum of 3 quarters · filed 2023-08-21 | $1.32M derived: sum of 4 quarters · filed 2023-08-21 | ||
| 2022-03-31 | $188.92K 10-Q · filed 2023-05-22 | $379.57K derived: sum of 2 quarters · filed 2023-05-22 | $1.14M derived: sum of 3 quarters · filed 2023-05-22 | $1.51M derived: sum of 4 quarters · filed 2023-05-22 | ||
| 2021-12-31 | $190.65K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-04-17 | $952.46K derived: sum of 2 quarters · filed 2023-04-17 | $1.32M derived: sum of 3 quarters · filed 2023-04-17 | $1.14M 10-K · filed 2023-04-17 | $1.95M 10-K/A · filed 2022-04-19 | |
| 2021-09-30 | $761.81K 10-Q/A · filed 2022-11-15 | $1.13M derived: sum of 2 quarters · filed 2022-11-15 | $953.08K 10-Q/A · filed 2022-11-15 | $2.95M derived: sum of 4 quarters · filed 2022-11-15 | ||
| 2021-06-30 | $371.13K 10-Q · filed 2022-08-16 | $91.53K 10-Q · filed 2021-08-23 | $191.27K 10-Q · filed 2022-08-16 | $2.18M derived: sum of 3 quarters · filed 2022-08-16 | $2.60M derived: sum of 4 quarters · filed 2022-08-16 | |
| 2021-03-31 | $99.74K 10-Q · filed 2022-08-16 | $1.81M derived: sum of 2 quarters · filed 2022-08-16 | $2.23M derived: sum of 3 quarters · filed 2022-08-16 | $2.23M derived: sum of 4 quarters · filed 2022-08-16 | ||
| 2020-12-31 | $1.71M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-26 | $2.13M derived: sum of 2 quarters · filed 2021-11-22 | $2.13M derived: sum of 3 quarters · filed 2021-11-22 | $1.95M 10-K/A · filed 2021-04-26 | ||
| 2020-09-30 | $414.84K 10-Q · filed 2021-11-22 | $414.84K derived: sum of 2 quarters · filed 2021-11-22 | $235.00K 10-Q · filed 2021-11-22 | |||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-23 | $0.00 10-Q · filed 2021-08-23 | ||||
| 2019-12-31 | $1.82M 10-K/A · filed 2021-04-26 |